DPHARMA-C5

0.000

(%)

STRUCTURED WARRANTS ANNOUNCEMENT : INITIAL OFFERING

DPHARMA-C5: CW DUOPHARMA BIOTECH BERHAD (AM)

Type Announcement
Subject STRUCTURED WARRANTS ANNOUNCEMENT
INITIAL OFFERING
Description
PROPOSED ISSUE OF UP TO 80,000,000 EUROPEAN STYLE NON-COLLATERALISED CASH-SETTLED CALL WARRANTS OVER ORDINARY SHARES OF DUOPHARMA BIOTECH BERHAD ("DPHARMA") ("DPHARMA SHARES") WITH AN EXERCISE RATIO OF 3 CALL WARRANTS : 1 DPHARMA SHARE ("DPHARMA-C5")

With reference to the above, AmBank is pleased to announce the proposed issue by AmBank of up to 80,000,000 European style non-collateralised cash-settled call warrants over ordinary shares of DPHARMA, to be listed on the Structured Warrants Board of Bursa Malaysia Securities Berhad.      

DPHARMAC5 is constituted by the Deed Poll dated 13 August 2021 executed by us, as supplemented from time to time. The DPHARMAC5 is subject to the terms and conditions of the Base Prospectus dated 24 August 2021, First Supplementary Base Prospectus dated 25 October 2021, Second Supplementary Base Prospectus dated 20 January 2022, Third Supplementary Base Prospectus dated 21 March 2022, Fourth Supplementary Base Prospectus dated 10 August 2022 and the Term Sheet for the DPHARMAC5 dated 17 August 2022.

A summary of the principal terms of the DPHARMAC5 is set out in Table 1.


This announcement is dated 17 August 2022.




Please refer attachment below.



Announcement Info

Company Name DPHARMA-C5: CW DUOPHARMA BIOTECH BERHAD (AM)
Stock Name DPHARMA-C5
Date Announced 17 Aug 2022
Category General Announcement for PLC
Reference Number GA1-17082022-00036